Cargando…

Targeted Radionuclide Therapy of Prostate Cancer—From Basic Research to Clinical Perspectives

Prostate cancer is the most commonly diagnosed malignancy in men and the second leading cause of cancer-related deaths in Western civilization. Although localized prostate cancer can be treated effectively in different ways, almost all patients progress to the incurable metastatic castration-resista...

Descripción completa

Detalles Bibliográficos
Autores principales:	Czerwińska, Malwina, Bilewicz, Aleksander, Kruszewski, Marcin, Wegierek-Ciuk, Aneta, Lankoff, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181060/ https://www.ncbi.nlm.nih.gov/pubmed/32290196 http://dx.doi.org/10.3390/molecules25071743

Ejemplares similares

Nanoparticle-Based Radioconjugates for Targeted Imaging and Therapy of Prostate Cancer
por: Lankoff, Anna, et al.
Publicado: (2023)

Design and Evaluation of (223)Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy–Part I
por: Czerwińska, Malwina, et al.
Publicado: (2020)

Coralyne Radiosensitizes A549 Cells by Upregulation of CDKN1A Expression to Attenuate Radiation Induced G2/M Block of the Cell Cycle
por: Węgierek-Ciuk, Aneta, et al.
Publicado: (2021)

A comparative analysis of in vitro toxicity of diesel exhaust particles from combustion of 1st- and 2nd-generation biodiesel fuels in relation to their physicochemical properties—the FuelHealth project
por: Lankoff, Anna, et al.
Publicado: (2017)

Design and Evaluation of (223)Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy—Part II. Toxicity, Pharmacokinetics and Biodistribution
por: Lankoff, Anna, et al.
Publicado: (2021)

Effects of Saponins against Clinical E. coli Strains and Eukaryotic Cell Line
por: Arabski, Michał, et al.
Publicado: (2012)

Genotoxic potential of diesel exhaust particles from the combustion of first- and second-generation biodiesel fuels—the FuelHealth project
por: Kowalska, Magdalena, et al.
Publicado: (2017)

Cisplatin Reduces the Frequencies of Radiotherapy-Induced Micronuclei in Peripheral Blood Lymphocytes of Patients with Gynaecological Cancer: Possible Implications for the Risk of Second Malignant Neoplasms
por: Węgierek-Ciuk, Aneta, et al.
Publicado: (2021)

Hypothermia differentially modulates the formation and decay of NBS1, γH2AX and 53BP1 foci in U2OS cells exposed to gamma radiation
por: Płódowska, Magdalena, et al.
Publicado: (2022)

Nanostructures as Radionuclide Carriers in Auger Electron Therapy
por: Gharibkandi, Nasrin Abbasi, et al.
Publicado: (2022)

Selective cytotoxicity and antifungal properties of copper(II) and cobalt(II) complexes with imidazole-4-acetate anion or 1-allylimidazole
por: Gałczyńska, Katarzyna, et al.
Publicado: (2019)

Functionalized TiO(2) nanoparticles labelled with (225)Ac for targeted alpha radionuclide therapy
por: Cędrowska, Edyta, et al.
Publicado: (2018)

Separation of Radionuclides from Spent Decontamination Fluids via Adsorption onto Titanium Dioxide Nanotubes after Photocatalytic Degradation
por: Lyczko, Monika, et al.
Publicado: (2020)

Clinical Advances and Perspectives in Targeted Radionuclide Therapy
por: Lepareur, Nicolas, et al.
Publicado: (2023)

(198)Au-Coated Superparamagnetic Iron Oxide Nanoparticles for Dual Magnetic Hyperthermia and Radionuclide Therapy of Hepatocellular Carcinoma
por: Gharibkandi, Nasrin Abbasi, et al.
Publicado: (2023)

Effect of Surface Functionalization on the Cellular Uptake and Toxicity of Nanozeolite A
por: Męczyńska-Wielgosz, Sylwia, et al.
Publicado: (2016)

Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer
por: Damiana, Tyrillshall S. T., et al.
Publicado: (2021)

Multifunctional Nanoparticles Based on Iron Oxide and Gold-198 Designed for Magnetic Hyperthermia and Radionuclide Therapy as a Potential Tool for Combined HER2-Positive Cancer Treatment
por: Żuk, Michał, et al.
Publicado: (2022)

Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
por: Müller, Cristina, et al.
Publicado: (2019)

Targeted Radionuclide Therapy
por: Ersahin, Devrim, et al.
Publicado: (2011)

Au@Pt Core-Shell Nanoparticle Bioconjugates for the Therapy of HER2+ Breast Cancer and Hepatocellular Carcinoma. Model Studies on the Applicability of (193m)Pt and (195m)Pt Radionuclides in Auger Electron Therapy
por: Wawrowicz, Kamil, et al.
Publicado: (2021)

Could veterinarians be immune to contracting SARS-CoV-2?
por: Kozłowska-Geller, Monika Anna, et al.
Publicado: (2022)

Novel radionuclide therapy combinations in prostate cancer
por: Inderjeeth, Andrisha–Jade, et al.
Publicado: (2023)

The Impact of Ag Nanoparticles and CdTe Quantum Dots on Expression and Function of Receptors Involved in Amyloid-β Uptake by BV-2 Microglial Cells
por: Sikorska, Katarzyna, et al.
Publicado: (2020)

Innovation in Radionuclide Therapy for the Treatment of Prostate Cancers: Radiochemical Perspective and Recent Therapeutic Practices
por: Deshayes, Emmanuel, et al.
Publicado: (2023)

Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer
por: Huynh, Truc T., et al.
Publicado: (2022)

Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies
por: Ahmadi Bidakhvidi, Niloefar, et al.
Publicado: (2021)

The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research
por: Ruigrok, Eline A.M., et al.
Publicado: (2019)

Targeted Radionuclide Therapy of Human Tumors
por: Gudkov, Sergey V., et al.
Publicado: (2015)

Introduction to Radiobiology of Targeted Radionuclide Therapy
por: Pouget, Jean-Pierre, et al.
Publicado: (2015)

Radionuclides for Targeted Therapy: Physical Properties
por: Stokke, Caroline, et al.
Publicado: (2022)

Targeting Melanin in Melanoma with Radionuclide Therapy
por: Allen, Kevin J. H., et al.
Publicado: (2022)

Targeted Radionuclide Therapy of Cancer and Infections
por: van der Wal, Bart C. H., et al.
Publicado: (2023)

Precision strikes: PSMA-targeted radionuclide therapy in prostate cancer – a narrative review
por: Szponar, Paweł, et al.
Publicado: (2023)

Nanoparticles in Targeted Alpha Therapy
por: Majkowska-Pilip, Agnieszka, et al.
Publicado: (2020)

Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases
por: Falzone, Nadia, et al.
Publicado: (2018)

Dietary Intervention with Blackcurrant Pomace Protects Rats from Testicular Oxidative Stress Induced by Exposition to Biodiesel Exhaust
por: Oczkowski, Michał, et al.
Publicado: (2022)

Prospects in Folate Receptor-Targeted Radionuclide Therapy
por: Müller, Cristina, et al.
Publicado: (2013)

Combination Strategies to Improve Targeted Radionuclide Therapy
por: Chan, Tiffany G., et al.
Publicado: (2020)

A Treatment Paradigm Shift: Targeted Radionuclide Therapies for Metastatic Castrate Resistant Prostate Cancer
por: Parent, Ephraim E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_stku21koepmfgqsdcgbrv397bn